[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [China Threat Triggers Potential Mining Boom for Investors]( [Discover the one company set to break China's grip on critical minerals]( --------------------------------------------------------------- March 09, 20223 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Minerals for Green Revolution a Massive Investor Opportunity]( for critical minerals needed to power green energy is expected to soar up to 40 times. China controls up to 90% of the desperately-needed supply and could throw the U.S. back into the stone age if it bans exports. One company is in hot pursuit of domestic sources with potentially big discoveries on the horizon. [Click here for this urgent investor alert]( --------------------------------------------------------------- [Ardelyx, ARDX]( Recent Analyst Action: Yigal Nochomovitz, analyst at Citigroup, reiterates coverage on [Ardelyx (ARDX)](in the Healthcare sector with a Buy rating and a price target of $7.00 (6 days ago). - Recent Price: $$4.085 - Average Analyst Price Target: $6.00 (46.88%) - Market Cap: $$813.58M [TipRanks.com]( also reports that [Ardelyx](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $6.00 . The target pricing ranges from a high forecast of $8.00 down to a low forecast of $3.00. [Ardelyx (ARDX)](’s last closing price was $$4.085 which would put the average price target at $$6.00. Here are 3rd party ratings for [ARDX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 36% (91 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Plan Could Devastate Your Retirement Savings]( Wall Street insider goes public with the true story of the most harmful action against the wealth of the American people. [See the proof here.]( --------------------------------------------------------------- [Samsara, IOT]( Recent Analyst Action: Alex Zukin, analyst at Wolfe Research, reiterates coverage on [Samsara (IOT)](in the Technology sector with a Buy rating and a price target of $22.00 (6 days ago). - Recent Price: $$21.34 - Average Analyst Price Target: $21.89 (2.58%) - Market Cap: $$10.86B [TipRanks.com]( also reports that [Samsara](currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $21.89 . The target pricing ranges from a high forecast of $29.00 down to a low forecast of $17.00. [Samsara (IOT)](’s last closing price was $$21.34 which would put the average price target at $$21.89. Here are 3rd party ratings for [IOT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Personalis, PSNL]( Recent Analyst Action: Patrick B, analyst at Citigroup, reiterates coverage on [Personalis (PSNL)](in the Healthcare sector with a Buy rating and a price target of $6.00 (1 week ago). - Recent Price: $$3.18 - Average Analyst Price Target: $6.80 (113.84%) - Market Cap: $$141.15M [TipRanks.com]( also reports that [Personalis](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $6.80 . The target pricing ranges from a high forecast of $10.00 down to a low forecast of $5.00. [Personalis (PSNL)](’s last closing price was $$3.18 which would put the average price target at $$6.80. Here are 3rd party ratings for [PSNL](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 28% (70 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Forget Tesla... Apple Car May Be The #1 EV Play]( Valley insider, Luke Lango, says his contacts are going crazy over Apple's latest project. Apple is preparing to upend the auto industry with their own EV... and this $5 stock could soar 40X once it goes live! [Click here to learn more.]( --------------------------------------------------------------- [TPI Composites, TPIC]( Recent Analyst Action: Kashy Harrison, analyst at Piper Sandler, reiterates coverage on [TPI Composites (TPIC)](in the Industrial Goods sector with a Hold rating and a price target of $15.00 (1 week ago). - Recent Price: $$14.05 - Average Analyst Price Target: $16.17 (15.09%) - Market Cap: $$548.73M [TipRanks.com]( also reports that [TPI Composites](currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.17 . The target pricing ranges from a high forecast of $19.00 down to a low forecast of $14.00. [TPI Composites (TPIC)](’s last closing price was $$14.05 which would put the average price target at $$16.17. Here are 3rd party ratings for [TPIC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 8% (19 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Dick's Sporting Goods, DKS]( Recent Analyst Action: Brian Nagel, analyst at Oppenheimer, reiterates coverage on [Dick's Sporting Goods (DKS)](in the Consumer Goods sector with a Buy rating and a price target of $175.00 (1 day ago). - Recent Price: $$151.48 - Average Analyst Price Target: $161.50 (7.35%) - Market Cap: $$12.24B [TipRanks.com]( also reports that [Dick's Sporting Goods](currently has 18 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $161.50 . The target pricing ranges from a high forecast of $200.00 down to a low forecast of $130.00. [Dick's Sporting Goods (DKS)](’s last closing price was $$151.48 which would put the average price target at $$162.61. Here are 3rd party ratings for [DKS](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 40% (101 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [CymaBay Therapeutics, CBAY]( Recent Analyst Action: Unknown Analyst, analyst at BTIG, reiterates coverage on [CymaBay Therapeutics (CBAY)](in the Healthcare sector with a Buy rating and a price target of $15.00 (10 hours ago). - Recent Price: $$9.25 - Average Analyst Price Target: $12.86 (41.95%) - Market Cap: $$854.02M [TipRanks.com]( also reports that [CymaBay Therapeutics](currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.86 . The target pricing ranges from a high forecast of $19.00 down to a low forecast of $8.00. [CymaBay Therapeutics (CBAY)](’s last closing price was $$9.25 which would put the average price target at $$13.13. Here are 3rd party ratings for [CBAY](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 28% (70 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Enlight Renewable Energy, ENLT]( Recent Analyst Action: Mark Strouse, analyst at J.P. Morgan, reiterates coverage on [Enlight Renewable Energy (ENLT)](in the Utilities sector with a Buy rating and a price target of $23.00 (2 days ago). - Recent Price: $$17.5 - Average Analyst Price Target: $21.75 (24.29%) - Market Cap: $$1.92B [TipRanks.com]( also reports that [Enlight Renewable Energy](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $21.75 . The target pricing ranges from a high forecast of $23.00 down to a low forecast of $21.00. [Enlight Renewable Energy (ENLT)](’s last closing price was $$17.5 which would put the average price target at $$21.75. Here are 3rd party ratings for [ENLT](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Hold, Bottom 36% (161 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["We will NEVER sell out to China!"]( says the CEO of an exploratory mining company advancing U.S. interests to secure U.S. domestic supplies of lithium, cobalt, and rare earth metals. These minerals are listed as "critical" for U.S. economic and national security. Yet China controls up to 90% of these markets and is aggressively locking up the rest. [Here's what investors urgently need to know in the rush for critical minerals]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software